BNP Paribas’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-95
Closed -$568 354
2026
Q1
$568 Sell
95
-90
-49% -$677 ﹤0.01% 325
2025
Q4
$1.32K Hold
185
﹤0.01% 334
2025
Q3
$1.95K Buy
185
+90
+95% +$883 ﹤0.01% 320
2025
Q2
$917 Hold
95
﹤0.01% 333
2025
Q1
$1.42K Hold
95
﹤0.01% 343
2024
Q4
$1.42K Hold
95
﹤0.01% 361
2024
Q3
$1.83K Hold
95
﹤0.01% 353
2024
Q2
$1.97K Sell
95
-59
-38% -$1.17K ﹤0.01% 321
2024
Q1
$2.87K Buy
+154
New +$2.64K ﹤0.01% 325

Other funds holding OGN

BNP Paribas's OGN Position: Q2 2026 in Review

BNP Paribas sold out of Organon & Co (OGN) in Q2 2026, closing a stake of 95 shares — an estimated $568 sold.

BNP Paribas first reported a position in OGN in Q1 2024 and held it in 9 quarters. The position peaked at $2.87K in Q1 2024. 633 funds tracked by Wall St. Rank hold OGN as of Q2 2026.

  • BNP Paribas reported no remaining Organon & Co position as of Q2 2026 after selling out during the quarter.
  • BNP Paribas sold 95 Organon & Co shares in Q2 2026, an estimated $568.
  • BNP Paribas first reported a position in Organon & Co in Q1 2024 and held it in 9 quarters.
  • BNP Paribas's Organon & Co position peaked at $2.87K in Q1 2024.
  • 633 funds tracked by Wall St. Rank held Organon & Co as of Q2 2026.

Based on BNP Paribas's 13F filing for Q2 2026, filed 13 Aug 2026.